English
Back
Open Account
博时国际
wrote a post · May 28 09:32
$Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK)$$Chinext Price Index (399006.SZ)$ The ChiNext Index has gained +26.31% year-to-date
Performance overview of the top 20 largest-weight stocks in the Shenzhen ChiNext market:
$Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK)$$Chinext Price Index (399006.SZ)$ The ChiNext Index has gained +26.31% year-to-date Performance overview of the top 20 largest-weight stocks in the Shenzhen ChiNext market: Investment involves risks. Past performance is not necessarily indicative of future results. Investors should not make investment decisions solely based on the information contained herein. The above information is for reference only and does not constitute or should not be regarded as an offer to subscribe or sell to any person. Before making any investment decision, investors should carefully read the relevant fund’s offering documents and product key facts statement, including the product features and risk factors described therein. Investors should assess whether the investment in the product is suitable based on their own investment experience, investment objectives, financial situation, and risk tolerance. If necessary, please seek independent professional advice. The above information has not been reviewed by the Securities and Futures Commission of Hong Kong. Publisher: Bosera International. No part of this document may be photocopied, distributed, or reproduced without the consent of Bosera International.
Investment involves risks. Past performance is not necessarily indicative of future results. Investors should not make investment decisions solely based on the information contained herein. The above information is for reference only and does not constitute or should not be regarded as an offer to subscribe or sell to any person. Before making any investment decision, investors should carefully read the relevant fund’s offering documents and product key facts statement, including the product features and risk factors described therein. Investors should assess whether the investment in the product is suitable based on their own investment experience, investment objectives, financial situation, and risk tolerance. If necessary, please seek independent professional advice. The above information has not been reviewed by the Securities and Futures Commission of Hong Kong.
Publisher: Bosera International. No part of this document may be photocopied, distributed, or reproduced without the consent of Bosera International.
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
1
45K Views
Report
Comments
Write a Comment...
1